USE OF ARACHIDONIC ACID AND/OR DOCOSAHEXANOIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DYSPRAXIA

摘要

Use of AA or DHA, desirably both, or in either case one or more precursor fatty acids, for the preparation of a medicament for treatment (including prophylaxis), by administration to children or pregnant women of dyspraxic or, specifically, poor fine and gross motor skills in dyspraxia or alternatively poor fine and gross motor skills in non-dyspraxic individuals, and such treatment and medicament in themselves.